Wednesday, April 19, 2017

BRIEF-Cytrx says FDA agreement on regulatory pathway for Aldoxorubicin

* Cytrx announces FDA agreement on regulatory pathway to

approval for Aldoxorubicin in soft tissue sarcomas

Read more

No comments:

Post a Comment